therapeutic vaccine

BIOLOGICAL2 trials

Sponsors

The First Affiliated Hospital of Guangdong Pharmaceutical University, Center of Molecular Immunology (CIM)

Conditions

Prostate Cancerhormonal castration-resistant prostate cancer, squamous cell carcinoma of the head and neck, and advanced colon cancer

Phase 1

Vaccine HER1 / VSSP for prostate cancer, head and neck carcinoma and advanced colon cancer . Phase I

Active, not recruitingRPCEC00000258

Center of Molecular Immunology (CIM)hormonal castration-resistant prostate cancer, squamous cell carcinoma of the head and neck, and advanced colon cancer

Start: 2017-11-15Target: 120Updated: 2026-03-30

Therapeutic Vaccine Plus PD-1 Knockout in Prostate Cancer Treatment

The First Affiliated Hospital of Guangdong Pharmaceutical UniversityProstate Cancer

Start: 2018-02-22End: 2021-08-30Target: 30Updated: 2018-05-16